The National Heart, Lung and Blood Institute Heart Failure Clinical Research Network designed the Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) study (NCT01800968) to test the hypothesis that liraglutide would improve myocardium bioenergetics leading to post-hospitalization clinical stability in subjects with advanced HF and reduced left ventricular ejection fraction, with and without diabetes [47]
However, Retatrutide remains investigational, and the safety profile is still developing
Definitive Healthcares commercial intelligence platform delivers powerful insights on pharmaceuticals, the providers prescribing them, and the patients who rely on them
Gastrointestinal: Mild transient diarrhea
Funding is overwhelmingly dominated by the US NIH, which, with current geopolitical and domestic US policy shifts, signals a concerning dependency that may prove disastrous in the near- and long-term future